The latest cancer drugs news
Browsing: Cancer Drug News
FDA grants accelerated approval to zongertinib for non-squamous NSCLC with HER2 TKD activating mutations
On August 8, 2025, the Food and Drug Administration granted accelerated approval to zongertinib, a…
New cancer drug boosts effectiveness of chemotherapy – even in resistant tumours
A groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours.…
NICE recommends ribociclib for eligible HR+/HER2- early breast cancer patients at high risk of recurrence
Novartis Pharmaceuticals UK announced that the National Institute for Health and Care Excellence (NICE) has…
FDA grants accelerated approval to linvoseltamab-gcpt for relapsed or refractory multiple myeloma
On July 2, 2025, the Food and Drug Administration granted accelerated approval to linvoseltamab-gcpt, a…
FDA grants accelerated approval to sunvozertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
On July 2, 2025, the Food and Drug Administration granted accelerated approval to sunvozertinib Pharmaceutical…
FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma
On June 18, 2025, the Food and Drug Administration approved tafasitamab-cxix with lenalidomide and rituximab…
Fixed-duration acalabrutinib-based regimens approved in EU for patients with chronic lymphocytic leukaemia in the 1st-line setting
A fixed-duration regimen of acalabrutinib in combination with venetoclax, with or without obinutuzumab, has been…
Thousands of blood cancer patients could benefit from new drug combination
Thousands of patients with a common type of blood cancer could benefit from a new…
ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129
The Ental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, has…
New method of taxol production has the potential to greatly reduce the cost
Taxol is one of the most commonly prescribed chemotherapy drugs for breast, ovarian, cervical, and…